Wilbanks Smith & Thomas Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$200K	–	515
2023 Q1	$200K	Hold	1,000	–	–	0.01%	490
2022 Q4	$238K	Hold	1,000	–	–	0.01%	433
2022 Q3	$200K	Buy	+1,000	New	+$200K	0.01%	449